Search research articles
Contact Us
Filters
Showing results (111-120 of 250) with videos related to
Page
of 25
Sort By:
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
January 24, 2015
Risk factors for selection of patients at high risk of recurrence or death after complete surgical resection in stage I gastric cancer
Ji Hyun Park, Min-Hee Ryu, Hwa Jung Kim, et al.
Cancer Immunology Research
|
April 9, 2020
CD226<sup>hi</sup>CD8<sup>+</sup> T Cells Are a Prerequisite for Anti-TIGIT Immunotherapy
Hyung-Seung Jin, Minkyung Ko, Da-Som Choi, et al.
In Vivo (Athens, Greece)
|
March 1, 2020
Rivaroxaban <i>Versus</i> Low-molecular-weight Heparin for Venous Thromboembolism in Advanced Upper Gastrointestinal Tract and Hepatopancreatobiliary Cancer
Jwa Hoon Kim, Seyoung Seo, Kyu-Pyo Kim, et al.
Oncotarget
|
November 5, 2017
Establishment and characterization of patient-derived xenograft models of gastrointestinal stromal tumor resistant to standard tyrosine kinase inhibitors
Young-Soon Na, Min-Hee Ryu, Changhoon Yoo, et al.
Cancer Research and Treatment
|
April 12, 2022
Establishing Patient-Derived Cancer Cell Cultures and Xenografts in Biliary Tract Cancer
Jihoon Kang, Ji-Young Lee, Sunmin Lee, et al.
The Lancet. Oncology
|
October 17, 2021
Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliary tract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study
Changhoon Yoo, Kyu-Pyo Kim, Jae Ho Jeong, et al.
Alimentary Pharmacology & Therapeutics
|
January 28, 2025
Risk of Variceal Bleeding in Patients Receiving Atezolizumab-Bevacizumab Treatment for Hepatocellular Carcinoma
Kanghee Park, Hye Won Lee, Euichang Kim, et al.
Journal of Digestive Diseases
|
July 4, 2017
Clinical outcomes of patients with resectable pancreatic acinar cell carcinoma
Seyoung Seo, Changhoon Yoo, Kyu-Poy Kim, et al.
Journal of Hepatology
|
March 27, 2025
Liposomal irinotecan for previously treated patients with biliary tract cancer: A pooled analysis of NIFTY and NALIRICC trials
Changhoon Yoo, Anna Saborowski, Jaewon Hyung, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 18, 2021
Efficacy and safety of atezolizumab plus bevacizumab in Korean patients with advanced hepatocellular carcinoma
Jaekyung Cheon, Changhoon Yoo, Jung Yong Hong, et al.
Page
of 25
Search research articles
Search
Showing results (111-120 of 250) with videos related to
Sort By:
Page
of 25
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
January 24, 2015
Risk factors for selection of patients at high risk of recurrence or death after complete surgical resection in stage I gastric cancer
Ji Hyun Park, Min-Hee Ryu, Hwa Jung Kim, et al.
Cancer Immunology Research
|
April 9, 2020
CD226<sup>hi</sup>CD8<sup>+</sup> T Cells Are a Prerequisite for Anti-TIGIT Immunotherapy
Hyung-Seung Jin, Minkyung Ko, Da-Som Choi, et al.
In Vivo (Athens, Greece)
|
March 1, 2020
Rivaroxaban <i>Versus</i> Low-molecular-weight Heparin for Venous Thromboembolism in Advanced Upper Gastrointestinal Tract and Hepatopancreatobiliary Cancer
Jwa Hoon Kim, Seyoung Seo, Kyu-Pyo Kim, et al.
Oncotarget
|
November 5, 2017
Establishment and characterization of patient-derived xenograft models of gastrointestinal stromal tumor resistant to standard tyrosine kinase inhibitors
Young-Soon Na, Min-Hee Ryu, Changhoon Yoo, et al.
Cancer Research and Treatment
|
April 12, 2022
Establishing Patient-Derived Cancer Cell Cultures and Xenografts in Biliary Tract Cancer
Jihoon Kang, Ji-Young Lee, Sunmin Lee, et al.
The Lancet. Oncology
|
October 17, 2021
Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliary tract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study
Changhoon Yoo, Kyu-Pyo Kim, Jae Ho Jeong, et al.
Alimentary Pharmacology & Therapeutics
|
January 28, 2025
Risk of Variceal Bleeding in Patients Receiving Atezolizumab-Bevacizumab Treatment for Hepatocellular Carcinoma
Kanghee Park, Hye Won Lee, Euichang Kim, et al.
Journal of Digestive Diseases
|
July 4, 2017
Clinical outcomes of patients with resectable pancreatic acinar cell carcinoma
Seyoung Seo, Changhoon Yoo, Kyu-Poy Kim, et al.
Journal of Hepatology
|
March 27, 2025
Liposomal irinotecan for previously treated patients with biliary tract cancer: A pooled analysis of NIFTY and NALIRICC trials
Changhoon Yoo, Anna Saborowski, Jaewon Hyung, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 18, 2021
Efficacy and safety of atezolizumab plus bevacizumab in Korean patients with advanced hepatocellular carcinoma
Jaekyung Cheon, Changhoon Yoo, Jung Yong Hong, et al.
Page
of 25